Rakesh Jogi

Cronología

Amigos

Fotos

Videos

Blogs

Páginas

Grupos

Eventos

Buscar

Middle East and Africa Neurostimulation Devices Market to Reach US$ 255.1 Million by 2033 at 3.7% CAGR

The Middle East and Africa neurostimulation devices industry is experiencing gradual but steady expansion as healthcare providers increasingly adopt advanced neuromodulation technologies for the treatment of chronic pain, Parkinson’s disease, epilepsy, movement disorders, and other neurological conditions. Neurostimulation devices deliver controlled electrical impulses to targeted areas...

Rakesh Jogi

2026-07-30 07:09:35

Más

North America Zinc Oxide Market to Reach US$ 1,242.3 Million by 2033 at 3.3% CAGR

The North America zinc oxide industry is witnessing steady expansion as demand continues to rise across automotive, construction, healthcare, and industrial manufacturing sectors. Zinc oxide is widely utilized for its excellent chemical stability, UV protection, antimicrobial properties, and reinforcing capabilities, making it an essential ingredient in rubber compounds, paints & coatings,...

Rakesh Jogi

2026-07-30 07:00:09

Más

Nordic Non-Invasive Neurostimulation Devices Market to Reach US$ 59.9 Million by 2033 at 12.7% CAGR

The Nordic non-invasive neurostimulation devices industry is witnessing robust expansion as healthcare providers increasingly adopt advanced brain stimulation technologies for the treatment of depression, chronic pain, neurological disorders, cognitive impairments, and rehabilitation applications. Non-invasive neurostimulation devices utilize electrical or magnetic stimulation to modulate...

Rakesh Jogi

2026-07-30 06:52:34

Más

Western Europe Invasive Neurostimulation Devices Market to Reach US$ 2.19 Billion by 2033 at 7.0% CAGR

The Western Europe invasive neurostimulation devices industry is witnessing strong expansion as healthcare providers increasingly adopt implantable neuromodulation technologies for the treatment of chronic pain, Parkinson’s disease, epilepsy, movement disorders, and other complex neurological conditions. Invasive neurostimulation devices deliver targeted electrical impulses to specific...

Rakesh Jogi

2026-07-29 07:06:54

Más

Benelux Invasive Neurostimulation Devices Market to Reach US$ 145.7 Million by 2033 at 6.8% CAGR

The Benelux invasive neurostimulation devices industry is witnessing steady expansion as healthcare providers increasingly adopt implantable neuromodulation technologies for the treatment of Parkinson’s disease, chronic pain, epilepsy, movement disorders, and other complex neurological conditions. Invasive neurostimulation devices deliver targeted electrical impulses to specific areas of...

Rakesh Jogi

2026-07-29 06:55:50

Más

North America Implantable Brain Stimulation Devices Market Analysis with US$ 5.95 Billion Forecast by 2033

The North America invasive neurostimulation devices industry is witnessing strong expansion as healthcare providers increasingly adopt implantable neuromodulation technologies for the treatment of chronic pain, Parkinson’s disease, epilepsy, movement disorders, and other complex neurological conditions. Invasive neurostimulation devices deliver targeted electrical impulses to specific...

Rakesh Jogi

2026-07-29 06:44:40

Más

Europe Vagus Nerve Stimulation Devices Market to Reach US$ 557.6 Million by 2033 at 8.9% CAGR

The Europe vagus nerve stimulation (VNS) devices industry is witnessing strong expansion as healthcare providers increasingly adopt advanced neuromodulation technologies for the treatment of drug-resistant epilepsy, depression, and other neurological disorders. Vagus nerve stimulation devices deliver controlled electrical impulses to the vagus nerve to regulate neural activity, helping improve...

Rakesh Jogi

2026-07-28 06:43:13

Más

GCC Deep Brain Stimulation Devices Market to Reach US$ 21.8 Million by 2033 at 3.8% CAGR

The GCC deep brain stimulation (DBS) devices industry is witnessing steady development as healthcare providers increasingly adopt advanced neuromodulation technologies for the treatment of movement disorders, including Parkinson’s disease, essential tremor, dystonia, and other neurological conditions. Deep brain stimulation devices deliver targeted electrical impulses to specific brain...

Rakesh Jogi

2026-07-28 06:32:02

Más

Asia Pacific Deep Brain Stimulation Devices Market to Reach US$ 560.6 Million by 2033 at 11.5% CAGR

The Asia Pacific deep brain stimulation (DBS) devices industry is witnessing rapid expansion as healthcare providers increasingly adopt advanced neuromodulation technologies for the treatment of Parkinson’s disease, epilepsy, essential tremor, dystonia, and other neurological disorders. Deep brain stimulation devices deliver targeted electrical impulses to specific brain regions, helping...

Rakesh Jogi

2026-07-28 06:23:31

Más

Latin America Spinal Cord Stimulation Devices Market to Reach US$ 273.6 Million by 2033 at 5.4% CAGR

The Latin America spinal cord stimulation (SCS) devices industry is witnessing steady expansion as healthcare providers increasingly adopt advanced neuromodulation technologies for the treatment of chronic pain, neuropathic pain, failed back surgery syndrome (FBSS), and other neurological conditions. Spinal cord stimulation devices deliver controlled electrical impulses to the spinal cord to...

Rakesh Jogi

2026-07-27 09:00:32

Más

Middle East and Africa Spinal Cord Stimulation Devices Market to Reach US$ 108.9 Million by 2033 at 3.1% CAGR

The Middle East and Africa spinal cord stimulation (SCS) devices industry is witnessing steady expansion as healthcare providers increasingly adopt advanced neuromodulation technologies for the treatment of chronic pain, neuropathic pain, failed back surgery syndrome (FBSS), and other neurological conditions. Spinal cord stimulation devices deliver controlled electrical impulses to the spinal...

Rakesh Jogi

2026-07-27 08:48:43

Más

Africa Neurostimulation Devices Market to Reach US$ 54.7 Million by 2033 at 3.4% CAGR

The Africa neurostimulation devices industry is witnessing steady expansion as healthcare providers increasingly adopt advanced neuromodulation technologies for the treatment of chronic pain, epilepsy, Parkinson’s disease, movement disorders, and other neurological conditions. Neurostimulation devices deliver targeted electrical impulses to specific areas of the nervous system, helping...

Rakesh Jogi

2026-07-27 07:42:32

Más